Effect of Dietary Inulin Supplementation on the Gut Microbiota Composition and Derived Metabolites of Individuals Undergoing Hemodialysis: A Pilot Study
- PMID: 34120835
- PMCID: PMC8403151
- DOI: 10.1053/j.jrn.2020.10.003
Effect of Dietary Inulin Supplementation on the Gut Microbiota Composition and Derived Metabolites of Individuals Undergoing Hemodialysis: A Pilot Study
Abstract
Objective: The prebiotic fiber inulin has been studied in individuals undergoing hemodialysis (HD) due to its ability to reduce gut microbiota-derived uremic toxins. However, studies examining the effects of inulin on the gut microbiota and derived metabolites are limited in these patients. We aimed to assess the impact of a 4-week supplementation of inulin on the gut microbiota composition and microbial metabolites of patients on HD.
Design and methods: In a randomized, double-blind, placebo-controlled, crossover study, twelve HD patients (55 ± 10 y, 50% male, 58% Black American, BMI 31.6 ± 8.9 kg/m2, 33% diabetes mellitus) were randomized to consume inulin [10 g/d for females; 15 g/d for males] or maltodextrin [6 g/d for females; 9 g/d for males] for 4 weeks, with a 4-week washout period. We assessed the fecal microbiota composition, fecal metabolites (short-chain fatty acids (SCFA), phenols, and indoles), and plasma indoxyl sulfate and p-cresyl sulfate.
Results: At baseline, factors that explained the gut microbiota variability included BMI category and type of phosphate binder prescribed. Inulin increased the relative abundance of the phylum Verrucomicrobia and its genus Akkermansia (P interaction = 0.045). Inulin and maltodextrin resulted in an increased relative abundance of the phylum Bacteroidetes and its genus Bacteroides (P time = 0.04 and 0.03, respectively). Both treatments increased the fecal acetate and propionate (P time = 0.032 and 0.027, respectively), and there was a trend toward increased fecal butyrate (P time = 0.06). Inulin did not reduce fecal p-cresol or indoles, or plasma concentrations of p-cresyl sulfate or indoxyl sulfate.
Conclusions: A 4-week supplementation of inulin did not lead to major shifts in the fecal microbiota and gut microbiota-derived metabolites. This may be due to high variability among participants and an unexpected increase in fecal excretion of SCFA with maltodextrin. Larger studies are needed to determine the effects of prebiotic fibers on the gut microbiota and clinical outcomes to justify their use in patients on HD.
Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study.Am J Clin Nutr. 2020 May 1;111(5):1087-1099. doi: 10.1093/ajcn/nqz337. Am J Clin Nutr. 2020. PMID: 31942927 Clinical Trial.
-
Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study.Br J Nutr. 2018 Jan;119(2):176-189. doi: 10.1017/S0007114517003440. Epub 2018 Jan 8. Br J Nutr. 2018. PMID: 29307330 Clinical Trial.
-
Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients.Eur J Nutr. 2022 Mar;61(2):665-677. doi: 10.1007/s00394-021-02669-y. Epub 2021 Sep 7. Eur J Nutr. 2022. PMID: 34491388 Clinical Trial.
-
Effects of Dietary Fibers on Short-Chain Fatty Acids and Gut Microbiota Composition in Healthy Adults: A Systematic Review.Nutrients. 2022 Jun 21;14(13):2559. doi: 10.3390/nu14132559. Nutrients. 2022. PMID: 35807739 Free PMC article. Review.
-
The Role of the Gut Microbiota in Complications among Hemodialysis Patients.Microorganisms. 2024 Sep 12;12(9):1878. doi: 10.3390/microorganisms12091878. Microorganisms. 2024. PMID: 39338552 Free PMC article. Review.
Cited by
-
Pea hull fiber supplementation does not modulate uremic metabolites in adults receiving hemodialysis: a randomized, double-blind, controlled trial.Front Nutr. 2023 Jun 30;10:1179295. doi: 10.3389/fnut.2023.1179295. eCollection 2023. Front Nutr. 2023. PMID: 37457968 Free PMC article.
-
Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis.Semin Dial. 2024 Jul-Aug;37(4):334-349. doi: 10.1111/sdi.13030. Epub 2021 Oct 27. Semin Dial. 2024. PMID: 34708456 Review.
-
A Symbiotic Meal Containing Extruded Sorghum and Probiotic (Bifidobacterium longum) Ameliorated Intestinal Health Markers in Individuals with Chronic Kidney Disease: A Secondary Analysis of a Subsample from a Previous Randomized and Controlled Clinical Trial.Nutrients. 2024 Jun 13;16(12):1852. doi: 10.3390/nu16121852. Nutrients. 2024. PMID: 38931207 Free PMC article. Clinical Trial.
-
Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level.Int J Mol Sci. 2022 Jan 17;23(2):991. doi: 10.3390/ijms23020991. Int J Mol Sci. 2022. PMID: 35055177 Free PMC article.
-
Letter to the Editor on the "Effects of Microbiota-driven Therapy on Circulating Indoxyl Sulfate and p-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".Adv Nutr. 2022 Mar;13(2):693-695. doi: 10.1093/advances/nmac010. Epub 2023 Feb 10. Adv Nutr. 2022. PMID: 37270212 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources